Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
Kurtz George0B / 239S · 10 late239 trades$59.22M
Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
TSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
DRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
MTDRMatador Resources CoNov 5 – Nov 99 insiders$642K
FERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
SYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
UPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
ADUSAddus HomeCare CorpNov 6 – Nov 96 insiders$16.28M
ARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 29 | Robinson Mark HaymondGeneral Counsel and Secretary |  GMEGameStop Corp.Open-market sale | SELL | $112K 5,475 sh | Jan 6, 2026 |
| 29 | Klein FrankChief Operations Officer | RKLBRocket Lab Corp Open-market sale · 10b5-1 plan | SELL | $183K 2,700 sh | Jan 6, 2026 traded Jan 2, 2026 |
| 27 | Bulis Veronica SanchezVP, Corporate Controller |  LYELLyell Immunopharma, Inc.Open-market sale | SELL | $30K 936 sh | Jan 6, 2026 traded Dec 30, 2025 |
| 27 | Rasmussen KrisChief Technology Officer | FIGFigma, Inc. Open-market sale · 10b5-1 plan | SELL | $4.41M 119.4K sh | Jan 6, 2026 traded Jan 5, 2026 |
| 27 | Rasmussen KrisChief Technology Officer | FIGFigma, Inc. Open-market sale · 10b5-1 plan | SELL | $2.01M 53.3K sh | Jan 6, 2026 traded Jan 5, 2026 |
| 26 | Bernstein HaroldPresident, R&D & CMO | MAZEMaze Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $179K 4,432 sh | Jan 6, 2026 traded Jan 2, 2026 |
| 26 | Hannay Michael Charles FergusonCHIEF PROD & SUPPLY CHAIN OFF |  BCYCBICYCLE THERAPEUTICS PLCOpen-market sale | SELL | $19K 2,827 sh | Jan 6, 2026 traded Jan 2, 2026 |
| 26 | Thompson Travis AlvinCHIEF ACCOUNTING OFFICER | BCYCBICYCLE THERAPEUTICS PLC Open-market sale | SELL | $8,956 1,317 sh | Jan 6, 2026 traded Jan 2, 2026 |
| 26 | Still AshleyDirector | DASHDoorDash, Inc. Open-market sale · 10b5-1 plan | SELL | $14K 63 sh | Jan 6, 2026 traded Jan 2, 2026 |
| 24 | Rasmussen KrisChief Technology Officer | FIGFigma, Inc. Open-market sale · 10b5-1 plan | SELL | $263K 7,017 sh | Jan 6, 2026 traded Jan 2, 2026 |
| 24 | Rasmussen KrisChief Technology Officer | FIGFigma, Inc. Open-market sale · 10b5-1 plan | SELL | $332K 8,662 sh | Jan 6, 2026 traded Jan 5, 2026 |
| 24 | Rasmussen KrisChief Technology Officer | FIGFigma, Inc. Open-market sale · 10b5-1 plan | SELL | $267K 7,235 sh | Jan 6, 2026 traded Jan 2, 2026 |
| 23 | Kelleher Eric RobertSee Remarks | OKTAOkta, Inc. Open-market sale · 10b5-1 plan | SELL | $144K 1,709 sh | Jan 6, 2026 traded Jan 2, 2026 |
| 23 | Bernstein HaroldPresident, R&D & CMO | MAZEMaze Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $16K 412 sh | Jan 6, 2026 traded Jan 5, 2026 |
| 22 | Raghavan VaidyanathanChief Technology Officer |  XMTRXometry, Inc.Open-market sale · 10b5-1 plan | SELL | $153K 2,291 sh | Jan 6, 2026 traded Jan 5, 2026 |
| 22 | Lin MarkEVP and CFO |  SMTCSEMTECH CORPOpen-market sale · 10b5-1 plan | SELL | $102K 1,333 sh | Jan 6, 2026 traded Jan 5, 2026 |
| 22 | Thompson Travis AlvinCHIEF ACCOUNTING OFFICER | BCYCBICYCLE THERAPEUTICS PLC Open-market sale | SELL | $7,192 1,115 sh | Jan 6, 2026 traded Jan 5, 2026 |
| 22 | Perez Daniel AntonioDirector, CEO & Co-Founder, 10% Owner |  HNGEHinge Health, Inc.Open-market sale · 10b5-1 plan | SELL | $5.66M 122.4K sh | Jan 6, 2026 traded Jan 5, 2026 |
| 22 | Hannay Michael Charles FergusonCHIEF PROD & SUPPLY CHAIN OFF | BCYCBICYCLE THERAPEUTICS PLC Open-market sale | SELL | $15K 2,367 sh | Jan 6, 2026 traded Jan 5, 2026 |
| 22 | Perez Daniel AntonioDirector, CEO & Co-Founder, 10% Owner | HNGEHinge Health, Inc. Open-market sale · 10b5-1 plan | SELL | $2.07M 44.3K sh | Jan 6, 2026 traded Jan 5, 2026 |
| 21 | Voskanian ShauntChief Revenue Officer | FIGFigma, Inc. Open-market sale · 10b5-1 plan | SELL | $231K 6,249 sh | Jan 6, 2026 traded Jan 5, 2026 |
| 21 | Voskanian ShauntChief Revenue Officer | FIGFigma, Inc. Open-market sale · 10b5-1 plan | SELL | $83K 2,200 sh | Jan 6, 2026 traded Jan 5, 2026 |
| 21 | Mulligan BrendanGeneral Counsel and Secretary | FIGFigma, Inc. Open-market sale · 10b5-1 plan | SELL | $127K 3,449 sh | Jan 6, 2026 traded Jan 2, 2026 |
| 21 | Voskanian ShauntChief Revenue Officer | FIGFigma, Inc. Open-market sale · 10b5-1 plan | SELL | $73K 1,936 sh | Jan 6, 2026 traded Jan 2, 2026 |
| 21 | Herb TylerChief Accounting Officer | FIGFigma, Inc. Open-market sale · 10b5-1 plan | SELL | $90K 2,440 sh | Jan 6, 2026 traded Jan 5, 2026 |
| 21 | Mulligan BrendanGeneral Counsel and Secretary | FIGFigma, Inc. Open-market sale · 10b5-1 plan | SELL | $125K 3,344 sh | Jan 6, 2026 traded Jan 2, 2026 |
| 21 | Mulligan BrendanGeneral Counsel and Secretary | FIGFigma, Inc. Open-market sale · 10b5-1 plan | SELL | $162K 4,366 sh | Jan 6, 2026 traded Jan 5, 2026 |
| 21 | Kosaraju SheelaSVP and General Counsel |  CIENCIENA CORPOpen-market sale · 10b5-1 plan | SELL | $421K 1,748 sh | Jan 6, 2026 traded Jan 2, 2026 |
| 21 | Voskanian ShauntChief Revenue Officer | FIGFigma, Inc. Open-market sale · 10b5-1 plan | SELL | $74K 1,997 sh | Jan 6, 2026 traded Jan 2, 2026 |
| 18 | Mulligan BrendanGeneral Counsel and Secretary | FIGFigma, Inc. Open-market sale · 10b5-1 plan | SELL | $49K 1,300 sh | Jan 6, 2026 traded Jan 5, 2026 |
| 18 | Sahni Sanjeev SinghPresident | XMTRXometry, Inc. Open-market sale · 10b5-1 plan | SELL | $64K 941 sh | Jan 6, 2026 traded Jan 5, 2026 |
| 18 | Sahni Sanjeev SinghPresident | XMTRXometry, Inc. Open-market sale · 10b5-1 plan | SELL | $189K 2,828 sh | Jan 6, 2026 traded Jan 5, 2026 |
| 18 | Bachrodt AmySVP, Finance | MAZEMaze Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $103K 2,595 sh | Jan 6, 2026 traded Jan 2, 2026 |
| 18 | Bachrodt AmySVP, Finance | MAZEMaze Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $93K 2,405 sh | Jan 6, 2026 traded Jan 2, 2026 |
| 18 | Herb TylerChief Accounting Officer | FIGFigma, Inc. Open-market sale · 10b5-1 plan | SELL | $45K 1,222 sh | Jan 6, 2026 traded Jan 2, 2026 |
| 18 | Herb TylerChief Accounting Officer | FIGFigma, Inc. Open-market sale · 10b5-1 plan | SELL | $15K 400 sh | Jan 6, 2026 traded Jan 5, 2026 |
| 18 | Herb TylerChief Accounting Officer | FIGFigma, Inc. Open-market sale · 10b5-1 plan | SELL | $45K 1,186 sh | Jan 6, 2026 traded Jan 2, 2026 |
| 17 | Mazzara PhilipGeneral Counsel and Secretary | ALABAstera Labs, Inc. Open-market sale · 10b5-1 plan | SELL | $462K 2,577 sh | Jan 6, 2026 traded Jan 2, 2026 |
| 17 | Mazzara PhilipGeneral Counsel and Secretary | ALABAstera Labs, Inc. Open-market sale · 10b5-1 plan | SELL | $411K 2,304 sh | Jan 6, 2026 traded Jan 2, 2026 |
| 16 | Kelleher Eric RobertSee Remarks | OKTAOkta, Inc. Open-market sale · 10b5-1 plan | SELL | $26K 300 sh | Jan 6, 2026 traded Jan 2, 2026 |